Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase

  • Gang Cheng
  • , Stephen P. Muench
  • , Ying Zhou
  • , Gustavo A. Afanador
  • , Ernest J. Mui
  • , Alina Fomovska
  • , Bo Shiun Lai
  • , Sean T. Prigge
  • , Stuart Woods
  • , Craig W. Roberts
  • , Mark R. Hickman
  • , Patty J. Lee
  • , Susan E. Leed
  • , Jennifer M. Auschwitz
  • , David W. Rice
  • , Rima McLeod*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan’s poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130.
Original languageEnglish
Pages (from-to)2035-2043
Number of pages9
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number7
Early online date12 Feb 2013
DOIs
Publication statusPublished - 1 Apr 2013
Externally publishedYes

Keywords

  • TgENR
  • triclosan
  • ADMET
  • Toxoplasma

Fingerprint

Dive into the research topics of 'Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase'. Together they form a unique fingerprint.

Cite this